Emerging research links GLP-1 drugs to potential reduction in breast cancer recurrence

New studies suggest that GLP-1 receptor agonists like Ozempic and Wegovy may be associated with lower breast cancer recurrence rates, though experts emphasise that further research is needed before changing clinical practices. Medicines such as Ozempic and Wegovy, which belong…













